Sanivap has been acquired by Oxy'Pharm
November 2019 — The private shareholders of Sanivap have sold the company to Oxy’Pharm.
With more than 15 years’ worth of experience, Sanivap is both a leader and a reference in the cleaning sector, where steam disinfection is used in many areas, including, but not limited to, healthcare, communal areas, agribusiness and transportation. The company offers a range of highly efficient and reliable products as well as user training services and technical services tailored to the needs of hygiene professionals.
Established in 2003, Oxy’Pharm manufactures and distributes biodegradable devices and products for automated surface disinfection and disinsection with an eco-friendly approach. The company is present in 50 countries and operates in the medical, pharmaceutical and agro-food sectors.
Our role in the transaction
Oaklins' team in France acted as the exclusive advisor to the seller in this transaction.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreGramo has completed a mandatory public takeover bid for the shares of Deceuninck
Gramo BV has completed a mandatory public takeover bid for the shares of Deceuninck NV. The bid was launched after Gramo’s conversion of warrants increased its participation in Deceuninck above the 30% voting rights threshold, thereby triggering a mandatory takeover bid under Belgian takeover legislation. The transaction further strengthens the stability of Deceuninck’s shareholder base and supports the company’s long-term strategy focused on innovation, sustainability and operational excellence.
Learn moreGVS has completed a voluntary partial tender offer for its own shares
GVS S.p.A. has completed a voluntary partial public tender offer for 12.3% of its own share capital.
Learn more